Abstract
Purpose
Inflammatory markers may have a role in predicting severity of illness of intensive care unit (ICU) patients. The aim of this study is to determine whether low eosinophil count can predict 28-day mortality in medical ICU.
Methods
A prospective study over a 4-month period. To evaluate the prognosis information provided by eosinophil count, we compared the variations in eosinophil count from ICU admission to seventh day between patients who survived and those who died. The best cutoff value was chosen using Younden’s index for identification of patients with high risk of mortality. The patient outcome was 28-day mortality.
Results
A total of 200 patients were eligible. Overall 28-day ICU mortality was 28% (n = 56). At ICU admission, the median eosinophil count was significantly different in survivors [30 cells/mm³; interquartile range (IQR), 0–100 cells/mm³] and nonsurvivors (0 cells/mm³; IQR, 0–30 cells/mm³; P = 0.004). Absolute eosinophil counts remained significantly lower in nonsurvivors from admission to seventh day. The 28-day mortality was significantly higher in patients with eosinopenia <40 cells/mm3 (P = 0.011). Multivariate analysis by Cox model with time-dependent covariates demonstrated that eosinophil count <40 cells/mm3 [hazard ratio (HR), 1.85; 95% confidence interval (CI), 1.01–3.42; P = 0.046], high Acute Physiology and Chronic Health Evaluation (APACHE) II score (HR, 1.08; 95% CI, 1.01–1.14; P = 0.014), high Sequential Organ Failure Assessment (SOFA) score (HR, 1.14; 95% CI, 1.03–1.25; P = 0.008), and use of mechanical ventilation (HR, 27.48; 95% CI, 12.12–62.28; P < 0.001) were independent predictors of 28-day all-cause mortality.
Conclusion
This study suggests the possibility to use eosinophil cell count at admission and during the first 7 days as a prognosis marker of mortality in medical ICU.
Similar content being viewed by others
References
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II A severity of disease classification system. Crit Care Med 13:818–829
Vincent JL, De Mendonca A, Cantrauine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of multicenter prospective study. Crit Care Med 26:1793–1800
Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on European/Nort American multicenter study. JAMA 270:2957–2963
Marshal JC, Cook DJ, Christou NV (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638–1652
Le Gall JR, Kler J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU scoring group. JAMA 276:802–810
Afessa B, Keegan MT, Mohammed Z, Finkielman JD, Peters SG (2004) Identifying potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 126:1905–1909
Baughman RP, Lower EE, Flessa HC, Tollerud DJ (1993) Thrombocytopenia in the intensive care unit. Chest 104:1243–1247
Stephan F, Hollande J, Richard O, Bonnet F (1999) Thrombocytopenia in a surgical ICU. Chest 115:1363–1370
Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871–1876
Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, Lassence AD, Zahar JR, Adrie C, Vincent F, Cohen Y, Schlemmer B, Azoulay E (2007) Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest 131:1735–1741
Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34:2596–2602
Lobo SMA, Lobo FRM, Bota DP, lopes-Ferreira F, Soliman HM, Mélot C, Vincent JL (2003) C-reactive protein levels correlate with patients mortality and organ failure in critically ill. Chest 123:2043–2049
Lopes-Ferreira F, Peres D, Bross A (2000) Serial evaluations of the SOFA score to predict outcome. JAMA 286:1754–1758
Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE (1980) Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest 65:1265–1271
Zappert J (1983) Ueber das vorkommen der eosinophilen zellen in menschlichen blute. Z Klin Med 23:227–308
Simon CE (1922) A manual of clinical diagnosis. Henry Klimpton, London 53
Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, Abouqal R (2008) Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 12:R59
Holland M, Alkhalil M, Chandromouli S, Janjua A, Babores M (2010) Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of obstructive pulmonary disease. Respirology 15:165–167
Charlson ME, Pompei P, Ales Kl, Mackenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Bone RC, Balk RA, Cerra Fb, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) American college of chest physicians/society of critical care medicine consensus conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655
Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, Niederman MS, Torres A (1998) Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 158:1102–1108
Cox DR (1972) Regression models and life-tables. J R Stat Soc 34:187–220
Crowley J, Hu M (1977) Covariance analysis of heart transplant survival data. J Am Stat Assoc 72:27–36
Therneau TM, Grambsch PM (2000) Modelling survival data: extending the Cox model. Springer, New York
Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38:709–750
Bass DA (1977) Reproduction of the eosinopenia of acute infection by passive transfer of a material obtained from inflammatory exudate. Infect Immun 15:410–416
Rothenberg ME (1998) Eosinophilia. N Engl J Med 338:1592–1600
Bass DA (1975) Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest 56:870–879
Gil H, Magy N, Mauny F, Dupond JL (2003) Value of eosinopenia in inflammatory disorders: an ‘old’ marker revisited. Rev Med Interne 24:431–435
Smithson A, Perello R, Nicolas JM (2009) Is eosinopenia a reliable marker of sepsis? Crit Care 13:409
Setterberg MJ, Newman W, Potti A, Smego RA (2004) Utility of eosinophil count as predictor of bacteremia. Clin Infect Dis 38:460–461
Metnitz B, Schaden E, Moreno R, Le Gall JR, Bauer P, Metnitz PG (2009) Austrian validation and customization of the SAPS 3 admission score. Intensive Care Med 35:616–622
Hardy JD (1950) The role of the adrenal cortex in the postoperative retention of salt and water. Ann Surg 132:189–197
Evans EI, Butterfield WJH (1951) The stress response in the severely burned: an interim report. Ann Surg 134:588–611
Sevitt S (1955) The spleen and blood eosinopenia. J Clin Pathol 8:42–46
Conflict of interest
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Drs. Abidi Khalid and Belayachi Jihane contributed equally to the work.
Rights and permissions
About this article
Cite this article
Abidi, K., Belayachi, J., Derras, Y. et al. Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med 37, 1136–1142 (2011). https://doi.org/10.1007/s00134-011-2170-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-011-2170-z